EMEA-000851-PIP01-10 - paediatric investigation plan

Pollen from Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, Poa pratensis, Secale cereale and Artemisia vulgaris

Key facts

• Active Substance:
  Pollen from Dactylis glomerata, Festuca pratensis, Lolium perenne, Phleum pratense, Poa pratensis, Secale cereale and Artemisia vulgaris
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/298/2010
• PIP number:
  EMEA-000851-PIP01-10
• Pharmaceutical form(s):
  Suspension for injection
• Condition(s) / indication(s):
  • Treatment of rhino-conjuctivitis
  • Treatment of allergic rhinitis
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  22/12/2010

Decision

P/298/2010: EMA decision of 22 December 2010 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for pollen from dactylis glomerata, festuca pratensis, l...

AdoptedReference Number: EMA/683426/2010